Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,810 | -7,923 | -3,882 | -1,602 | -15,010 |
| Depreciation Amortization | 10 | 13 | 9 | 5 | 70 |
| Other Working Capital | -320 | -350 | -437 | -400 | 1,390 |
| Other Operating Activity | 1,550 | 1,837 | -386 | -785 | 650 |
| Operating Cash Flow | $-9,570 | $-6,423 | $-4,695 | $-2,783 | $-12,900 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -7 | -3 | -3 | 40 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 40 |
| Investing Cash Flow | $-10 | $-7 | $-3 | $-3 | $80 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 10,000 | 4,000 | 4,000 | N/A | N/A |
| Debt Repayment | N/A | -210 | -210 | N/A | N/A |
| Common Stock Issued | 57,815 | -642 | 49 | 49 | N/A |
| Other Financing Activity | 13,355 | 13,568 | 7,993 | 7,875 | 6,080 |
| Financing Cash Flow | $81,170 | $16,717 | $11,832 | $7,924 | $6,080 |
| Beginning Cash Position | 4,360 | 4,364 | 4,364 | 4,364 | 11,090 |
| End Cash Position | 75,940 | 14,650 | 11,498 | 9,503 | 4,360 |
| Net Cash Flow | $71,580 | $10,286 | $7,134 | $5,139 | $-6,730 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,570 | -6,423 | -4,695 | -2,783 | -12,900 |
| Capital Expenditure | -18 | -7 | -3 | -3 | N/A |
| Free Cash Flow | -9,588 | -6,430 | -4,698 | -2,786 | -12,900 |